HRP20090190T1 - Pharmaceutical composition comprising a salt of mirtazapine - Google Patents

Pharmaceutical composition comprising a salt of mirtazapine

Info

Publication number
HRP20090190T1
HRP20090190T1 HR20090190T HRP20090190T HRP20090190T1 HR P20090190 T1 HRP20090190 T1 HR P20090190T1 HR 20090190 T HR20090190 T HR 20090190T HR P20090190 T HRP20090190 T HR P20090190T HR P20090190 T1 HRP20090190 T1 HR P20090190T1
Authority
HR
Croatia
Prior art keywords
salt
mirtazapine
pharmaceutical composition
acid salt
subliming
Prior art date
Application number
HR20090190T
Other languages
English (en)
Croatian (hr)
Inventor
Hyke Moolenaar Sytske
Johannes Kemperman Gerardus
Van Der Voort Maarschalk Kees
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of HRP20090190T1 publication Critical patent/HRP20090190T1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20090190T 2004-04-21 2009-03-31 Pharmaceutical composition comprising a salt of mirtazapine HRP20090190T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04101664 2004-04-21
PCT/EP2005/051714 WO2005102352A1 (en) 2004-04-21 2005-04-19 Pharmaceutical composition comprising a salt of mirtazapine

Publications (1)

Publication Number Publication Date
HRP20090190T1 true HRP20090190T1 (en) 2009-05-31

Family

ID=34928990

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090190T HRP20090190T1 (en) 2004-04-21 2009-03-31 Pharmaceutical composition comprising a salt of mirtazapine

Country Status (31)

Country Link
US (1) US20070111993A1 (es)
EP (1) EP1729777B1 (es)
JP (2) JP5260959B2 (es)
CN (2) CN101824035A (es)
AR (1) AR049028A1 (es)
AT (1) ATE424210T1 (es)
AU (1) AU2005235383B2 (es)
BR (1) BRPI0509953A (es)
CA (1) CA2561281C (es)
CY (1) CY1109018T1 (es)
DE (1) DE602005013066D1 (es)
DK (1) DK1729777T3 (es)
EC (1) ECSP066938A (es)
ES (1) ES2321961T3 (es)
HR (1) HRP20090190T1 (es)
IL (1) IL178201A (es)
LV (1) LV13556B (es)
MX (1) MXPA06011830A (es)
MY (1) MY144899A (es)
NO (1) NO20065077L (es)
NZ (1) NZ550052A (es)
PE (1) PE20060400A1 (es)
PL (1) PL1729777T3 (es)
PT (1) PT1729777E (es)
RS (1) RS50764B (es)
RU (1) RU2375362C2 (es)
SI (1) SI1729777T1 (es)
TW (1) TW200538100A (es)
UA (1) UA89773C2 (es)
WO (1) WO2005102352A1 (es)
ZA (1) ZA200608305B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
EP1792618A1 (en) * 2005-11-30 2007-06-06 Rainer Freynhagen R-mirtazapine for the treatment of pain
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
CN104095824B (zh) * 2013-04-09 2016-08-31 上海信谊万象药业股份有限公司 一种米氮平缓释片及其制备方法
PL3261645T3 (pl) 2015-02-27 2021-12-06 Dechra Limited Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4193828A (en) * 1976-07-27 1980-03-18 Fiber Materials, Inc. Method of forming carbon composites
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
AU747975B2 (en) * 1998-04-02 2002-05-30 N.V. Organon Oral liquid antidepressant solution
WO2001000196A2 (en) * 1999-06-25 2001-01-04 University Of South Florida Mirtazapine for weight gain in wasting diseases
US6281207B1 (en) * 1999-09-15 2001-08-28 Reed Richter Treatment of movement disorders by administration of mirtazapine
AU6474200A (en) * 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
ES2201039T3 (es) * 2000-04-05 2004-03-16 Akzo Nobel N.V. Combinacion de farmacos para el tratamiento del dolor de cabeza que comprende un farmaco anti-inflamatorio no esteroideo.

Also Published As

Publication number Publication date
UA89773C2 (ru) 2010-03-10
US20070111993A1 (en) 2007-05-17
SI1729777T1 (sl) 2009-08-31
IL178201A (en) 2010-06-30
RS50764B (sr) 2010-08-31
CA2561281A1 (en) 2005-11-03
CN1942191A (zh) 2007-04-04
PL1729777T3 (pl) 2009-07-31
JP2007533705A (ja) 2007-11-22
AU2005235383B2 (en) 2010-05-27
NO20065077L (no) 2006-11-14
DK1729777T3 (da) 2009-06-08
TW200538100A (en) 2005-12-01
EP1729777A1 (en) 2006-12-13
ES2321961T3 (es) 2009-06-15
DE602005013066D1 (de) 2009-04-16
MY144899A (en) 2011-11-30
WO2005102352A1 (en) 2005-11-03
RU2006140988A (ru) 2008-05-27
AR049028A1 (es) 2006-06-21
IL178201A0 (en) 2006-12-31
LV13556B (en) 2007-07-20
EP1729777B1 (en) 2009-03-04
JP2013136626A (ja) 2013-07-11
CY1109018T1 (el) 2014-07-02
CN101824035A (zh) 2010-09-08
MXPA06011830A (es) 2007-03-23
CA2561281C (en) 2013-04-02
NZ550052A (en) 2010-02-26
AU2005235383A1 (en) 2005-11-03
PE20060400A1 (es) 2006-05-27
PT1729777E (pt) 2009-04-27
BRPI0509953A (pt) 2007-09-25
ZA200608305B (en) 2008-08-27
RU2375362C2 (ru) 2009-12-10
CN1942191B (zh) 2011-02-02
ATE424210T1 (de) 2009-03-15
JP5260959B2 (ja) 2013-08-14
ECSP066938A (es) 2006-12-20

Similar Documents

Publication Publication Date Title
CY1120138T1 (el) Στερεη φαρμακευτικη μορφη δοσολογιας που περιλαμβανει μια στερεη διασπορα αναστολεα πρωτεασης toy hiv
HRP20090190T1 (en) Pharmaceutical composition comprising a salt of mirtazapine
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
RS51516B (en) ADDITIONAL HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS
RS53371B (en) METHOD OF USE DEFERRED AMINOPYRIDINE COMPOSITION
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
WO2004062577A3 (en) Two or more enteric materials to regulate drug release
HRP20010573B1 (en) Tricyclic inhibitors of poly(adp-ribose) polymerases
HRP20060240T3 (en) Intranasal formulation of rotigotine
DK1178958T3 (da) N-cyanomethylamider som proteaseinhibitorer
DE60124587D1 (de) 2-butyl-3-(4-3(dibutylamino)propoxyü benzoyl)-5-nitrobenzofuran-hydrochlorid und dessen herstellung
WO2006035417A3 (en) Dihydropyrimidine microcapsule - formulations
ITFI20050042A1 (it) N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell'istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche
RS51271B (sr) Čvrsta farmaceutska kompozicija koja sadrži donepezil hidrohlorid
RS52891B (en) GASTRORE-RESISTANT PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMINE
TW200635897A (en) Piperidine derivatives and their use as anti-inflammatory agents
GEP20104878B (en) Inhibitors of microsomal triglyceride transfer protein and apo-b secretion
SG164288A1 (en) Chemokine receptor antagonists
CY1109523T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα παραγωγο βενζοδιαζεπινης και εναν αναστολεα της πρωτεϊνης συντηξης rsv
NO20024387L (no) Karboksylsyrederivater som IP-antagonister
WO2005075450A3 (en) Spiro-benzodioxoles and their use as cb1 antagonists
RS53428B (en) COMPOSITIONS AND ANTI-VIRUS ACTIVITY OF SUBSTITUTED AZAINDOLOXOSCETER PIPERAZINE DERIVATIVES
RS53507B1 (en) PHARMACEUTICAL COMPOSITION AGAINST MALARIA
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
HRP20090022T3 (en) Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences